Connection

Danielle Anderson to Influenza A Virus, H3N2 Subtype

This is a "connection" page, showing publications Danielle Anderson has written about Influenza A Virus, H3N2 Subtype.
  1. Identification and in vivo Efficacy Assessment of Approved Orally Bioavailable Human Host Protein-Targeting Drugs With Broad Anti-influenza A Activity. Front Immunol. 2019; 10:1097.
    View in: PubMed
    Score: 0.138
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.